Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.
about
NK Cells in HIV DiseaseConformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategiesFc functional antibodies in humans with severe H7N9 and seasonal influenzaHIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers.Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens.Modest attenuation of HIV-1 Vpu alleles derived from elite controller plasmaIsotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection.HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humansEnv-Specific IgA from Viremic HIV-Infected Subjects Compromises Antibody-Dependent Cellular CytotoxicityDevelopment of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters.Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and DenmarkA new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection.Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort.Indian Long-term Non-Progressors Show Broad ADCC Responses with Preferential Recognition of V3 Region of Envelope and a Region from Tat ProteinEnhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgG.Role of Fc-mediated antibody function in protective immunity against HIV-1.Natural killer cell heterogeneity: cellular dysfunction and significance in HIV-1 immuno-pathogenesis.Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?Increased, durable B-cell and ADCC Responses Associated with T-helper Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent MannerDiversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects.Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.HIV-specific antibody-dependent phagocytosis matures during HIV infection.Vaccines licensed and in clinical trials for the prevention of dengue.Divergent Expression of CXCR5 and CCR5 on CD4+ T Cells and the Paradoxical Accumulation of T Follicular Helper Cells during HIV Infection.Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial.Granulocyte-macrophage colony-stimulating factor, a potent adjuvant for polarization to Th-17 pattern: an experience on HIV-1 vaccine model.Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56+ natural killer cell responses in chronic HCV-infected patients.A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region.Proliferation of functional human natural killer cells with anti-HIV-1 activity in NOD/SCID/Jak3(null) mice.Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.
P2860
Q26752833-3F724810-C8F1-46DA-B52E-B6DE9DEE5526Q26782237-2F6095DF-C860-45FC-96DF-6E8043AA6F2FQ26799624-24C21788-ECF8-4ACF-BA80-D5BA8F2D9DD4Q33877811-28208FF5-A1F9-4B7B-BF79-0059EB6364DAQ33887674-DE503402-90FA-40B0-8186-3CBAE8580C58Q34869927-E70B8D8A-90C4-4637-BBE2-B79742FCF1D2Q35005192-65281E31-EC66-4793-8F6A-D9D14BE88CFDQ35415717-CC69C757-6E72-4F7A-8250-97A0A26E54D1Q35566508-6F03A83C-47E5-40B9-8058-7FEC5C26A27EQ35582429-C8890E8C-9E14-4DA1-B93D-DD513C160430Q35826668-AAAF9329-9DDD-4F90-9C9F-E2DAEEAC62EFQ35876207-067A1143-E996-46CA-B356-38A4DD891B45Q36252656-6EE848BF-92E6-45FA-A4CC-05D402500D00Q36434229-798B9FA2-0DD6-4192-99A5-7FCB7338CEBFQ36479067-D3E17A36-5D59-46B8-A183-C6FF0EDBF84CQ36837324-B9CB7E24-7C21-401B-BBF2-A0715E702A49Q36906910-5DE4A582-692E-4F8F-A7D2-81B651A08505Q37396363-BD12FE7B-D965-4478-8355-6494DCC40204Q37426168-70ABD562-D675-4E26-8350-DC40D0E02F23Q37523341-F7723736-FA64-4A89-B1D6-9916D55F1510Q37592654-963F44CF-653E-4E9F-B06E-B3331A9F3E3FQ37646897-1EBEEC36-9B38-4575-BE56-2FFC06CC759CQ38213061-D0632386-B651-4EEA-8F2B-A19666625C01Q38457805-B0010F13-F99E-4455-A2FB-048BD7071CC5Q38527822-A08074E7-9355-44EF-9E64-AF3B28600071Q38658529-C16B0491-6B87-45DF-9250-F8C318CAB613Q38682077-4C88D6C0-2BF2-42FF-B00D-DC165CE8212CQ38719420-B424CBDC-0241-4510-B7E4-4302F4031688Q38727815-03CE8BD6-466F-4B62-B07D-82BBB27D2576Q38812544-7EECA365-F9DA-4E3A-B85B-8A0C85819E3BQ38873975-4D77C48B-02CC-4FE6-A6B8-6F10142FD9C7Q39172722-8CC09E1D-9E33-49EC-8484-4AB54504D9D8Q39335635-8A87AA3B-9C27-4198-A09D-1B800EED50ACQ40172220-D4B41260-C5A2-4649-AD77-C2C01CD1460DQ40217417-355877CB-1924-4C22-A9C6-054B5BF5BEB3Q40286085-D30DF529-BC38-446F-8DE4-614FD2C7E84AQ40336664-665B41A1-6052-4719-9376-E9420E7C19D4Q40730039-829641D4-BB6D-4C92-B919-80B3F4DC5231Q40855777-F60534C4-5278-4158-901D-6356CF515BE0Q41508499-37DA64AA-3FB3-4513-86F5-930A87141EC9
P2860
Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Specific antibody-dependent ce ...... progression of HIV infection.
@en
Specific antibody-dependent ce ...... progression of HIV infection.
@nl
type
label
Specific antibody-dependent ce ...... progression of HIV infection.
@en
Specific antibody-dependent ce ...... progression of HIV infection.
@nl
prefLabel
Specific antibody-dependent ce ...... progression of HIV infection.
@en
Specific antibody-dependent ce ...... progression of HIV infection.
@nl
P2093
P2860
P50
P356
P1433
P1476
Specific antibody-dependent ce ...... progression of HIV infection.
@en
P2093
ADCC study collaboration investigators
Anthony D Kelleher
David A Cooper
Gamze Isitman
Ivan Stratov
Leia H Wren
Marjon Navis
Matthew S Parsons
P2860
P304
P356
10.1111/IMM.12016
P577
2013-02-01T00:00:00Z